Cargando…
Transcriptomics Analysis of the Tumor-Inhibitory Pathways of 6-Thioguanine in MCF-7 Cells via Silencing DNMT1 Activity
BACKGROUND: 6-thioguanine (6-TG), as a conventional “ancient” drug for the treatment of acute leukemia, has been proved to have extensive anti-tumor roles. This study was created to investigate the hidden function of 6-TG on the MCF-7 breast cancer cell line (ER+, PR+) and its mechanisms. METHODS: M...
Autores principales: | Li, Hao, An, Xinglan, Zhang, Daoyu, Li, Qi, Zhang, Nan, Yu, Hao, Li, Ziyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023860/ https://www.ncbi.nlm.nih.gov/pubmed/32103989 http://dx.doi.org/10.2147/OTT.S236543 |
Ejemplares similares
-
Construction and analysis of competing endogenous RNA network of MCF-7 breast cancer cells based on the inhibitory effect of 6-thioguanine on cell proliferation
por: Li, Hao, et al.
Publicado: (2021) -
Thioguanine Induces Apoptosis in Triple-Negative Breast Cancer by Regulating PI3K–AKT Pathway
por: Zhang, Daoyu, et al.
Publicado: (2020) -
The regulatory effect of 6-TG on lncRNA–miRNA–mRNA ceRNA network in triple-negative breast cancer cell line
por: Zhang, Daoyu, et al.
Publicado: (2021) -
6-Thioguanine and zebularine down-regulate DNMT1 and globally demethylate canine malignant lymphoid cells
por: Flesner, Brian K, et al.
Publicado: (2014) -
Effect of 6-thioguanine on the stability of duplex DNA
por: Bohon, Jen, et al.
Publicado: (2005)